Suicide prevention is the Department of Veterans Affairs No. 1 clinical priority. The agency's Executive Director of Suicide Prevention Matthew Miller unpacks new programs and initiatives aimed at reducing veteran suicide, like VA's recently announced Mission Daybreak. He'll also discuss the technologies that are helping VA meet this critical goal.

Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation's most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.

The Department of Veterans Affairs is at the forefront of some of America's most advanced brain health research. Ahead of the VA NAII BRAIN Summit in Washington D.C., Dr. Rafael Fricks discusses how VA is applying breaking technology like artificial intelligence and machine learning to better understand and treat complex conditions ranging from brain cancer to post-traumatic stress disorder and traumatic brain injury.

Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to advance disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of precision medicine and immunotherapy.

The Department of Veterans Affairs is at the forefront of advancing America's health care and using new capacities to improve patient outcomes. Dr. Priya Joshi discusses how the agency is developing a set of rigorous clinical standards to ensure technology is adopted in a safe, effective way to improve the treatment and quality of life for veterans nationwide.

The Department of Veterans Affairs is making considerable advancements in wearable devices and remote patient monitoring to keep track of symptoms and key health metrics in near real time. VA Innovation Specialist Dr. Lindsay Riegler provides a look at how the agency is incorporating these within its broader health care program to improve treatment of chronic conditions such as diabetes and hypertension.

In June, a study supported by the National Cancer Institute found that for people with HIV, early treatment of precancerous anal lesions caused by human papillomavirus (HPV) can cut rates of anal cancer incidence by more than half. These findings from the Anal Cancer/HSIL Outcomes Research (ANCHOR) study are creating secondary prevention options for those at risk for anal cancer who have not received the HPV vaccine. We look into the history of the study and what its work means for those at risk for anal cancer. 

The Veterans Health Administration has focused much of its modernization programs on improving access to essential care. Director of the Veterans Transportation Program Ben Williams and VHA Executive Management Fellow Indra Sandal discuss the new VHA-Uber Health Connect pilot helping veterans access the care they need while significantly reducing costs from missed appointments.

The Department of Veterans Affairs has been overseeing some of America's most promising and impactful research into the treatment and management of diabetes. Dr. Leonard Pogach, a lifelong diabetes specialist at VA, highlights the agency's critical work in advancing the understanding of one of America's most commonly suffered chronic illnesses.

The Department of Veterans Affairs oversees both America's largest integrated health care network as well as some of the nation's most impactful and wide-reaching health care research projects. VA Director of the Clinical Epidemiology Center Dr. Ziyad al-Aly describes how the agency is using a large repository of health care information and expertise treating COVID-19 to oversee research into better addressing the condition's enduring symptoms long term.